The government should be making efforts to test 'medically and socially disadvantaged people' who are more likely to contract Covid-19, but still don't have access to testing, Dr. Scott Gottlieb said.
The coronavirus epidemic in the U.S. is expanding and the U.S. still has not put the necessary infrastructure in place to prevent a major second wave in the fall, former Food and Drug Administration Commissioner Dr. Scott Gottlieb says.
." "We're going to have the testing in place, the capacity to run the testing. I think we still have a challenge with the collection sites, moving the testing into places where people are at risk." Since the beginning of the outbreak, some health officials and epidemiologists have called on the government to test broadly for the coronavirus and to track the contacts of those recently infected in order to contain the virus. However, such efforts are costly and demand a large workforce of trained personnel.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA struggles to remain independent amid race for virus cureThe unprecedented effort by the White House to intercede at the FDA is raising alarms among health experts inside and outside the administration
Read more »
Antidepressant Zoloft and generic version in short supply, FDA saysA spike in demand for anxiety and depression drugs has led to shortages of some forms of the commonly used antidepressant Zoloft and its generic, sertraline.
Read more »
Antidepressant Zoloft and generic version in short supply, FDA saysThe shortage follows a sharp increase in reports of depression and anxiety in the U.S.
Read more »
Hype and science collide as FDA tries to rein in 'wild West' of COVID-19 blood testsThe FDA is trying to rein in the chaos it created by allowing companies to flood the market with COVID-19 antibody tests of questionable accuracy.
Read more »
Column: Study concludes chloroquine drugs promoted by Trump are worthless against coronavirusColumn: Major study concludes chloroquine antimalarials are worthless against coronavirus
Read more »